Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans
Masaaki Yamamoto, … , Kazuo Chihara, Yutaka Takahashi
Masaaki Yamamoto, … , Kazuo Chihara, Yutaka Takahashi
Published December 1, 2010
Citation Information: J Clin Invest. 2011;121(1):113-119. https://doi.org/10.1172/JCI44073.
View: Text | PDF
Research Article Endocrinology

Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans

  • Text
  • PDF
Abstract

The pituitary-specific transcriptional factor-1 (PIT-1, also known as POU1F1), is an essential factor for multiple hormone-secreting cell types. A genetic defect in the PIT-1 gene results in congenital growth hormone (GH), prolactin (PRL), and thyroid-stimulating hormone (TSH) deficiency. Here, we investigated 3 cases of adult-onset combined GH, PRL, and TSH deficiencies and found that the endocrinological phenotype in each was linked to autoimmunity directed against the PIT-1 protein. We detected anti–PIT-1 antibody along with various autoantibodies in the patients’ sera. An ELISA-based screening revealed that this antibody was highly specific to the disease and absent in control subjects. Immunohistochemical analysis revealed that PIT-1–, GH-, PRL-, and TSH-positive cells were absent in the pituitary of patient 2, who also had a range of autoimmune endocrinopathies. These clinical manifestations were compatible with the definition of autoimmune polyendocrine syndrome (APS). However, the main manifestations of APS-I — hypoparathyroidism and Candida infection — were not observed and the pituitary abnormalities were obviously different from the hypophysitis associated with APS. These data suggest that these patients define a unique “anti–PIT-1 antibody syndrome,” related to APS.

Authors

Masaaki Yamamoto, Genzo Iguchi, Ryoko Takeno, Yasuhiko Okimura, Toshiaki Sano, Michiko Takahashi, Hitoshi Nishizawa, Anastasia Evi Handayaningshi, Hidenori Fukuoka, Maya Tobita, Takatoshi Saitoh, Katsuyoshi Tojo, Atsuko Mokubo, Akio Morinobu, Keiji Iida, Hidesuke Kaji, Susumu Seino, Kazuo Chihara, Yutaka Takahashi

×

Figure 1

Immunoblotting analysis of mouse tissues and cell lysates.

Options: View larger image (or click on image) Download as PowerPoint
Immunoblotting analysis of mouse tissues and cell lysates.
The patients’...
The patients’ serum was used as a primary antibody (1:1000) to detect the autoantibody. (A–C) The patients’ sera specifically recognized a 33-kDa protein in the lysates from the pituitary and GH3 cells (arrow). (B) The serum of patient 2 recognizes a 150-kDa protein in the pancreas (arrowhead), but the size of this protein does not correspond to that of insulin (58 kDa) or GAD (65 kDa). (C) The serum of patient 3 recognized approximately 45 kDa protein as a nonspecific band in addition to the 33-kDa protein PIT-1. (D) Representative results of the healthy control subjects are shown. Neither the sera of 10 healthy control subjects nor those of 8 patients with pituitary adenoma and 6 patients with hypophysitis recognized the 33-kDa protein. (E) The patients’ sera detected the 33-kDa protein in the lysate from human pituitary. (F) The patients’ sera detected the PIT-1 protein in the lysates from GH3, hPIT-1–expressing Cos7, and 293T cells (arrows).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts